First and foremost, while the pivotal role of EZH2/PRC2 in promoting and counteracting cancer in HNSCC has been extensively investigated, further elucidation is needed regarding the regulation of its diverse expression mechanisms in HNSCC patients across different clinical scenarios. The gene discussed is EZH2; the disease is cancer.